期刊文献+

新生儿缺氧缺血性脑病血清IL-10水平变化及临床意义 被引量:4

The Clinical Significance of the Change of Serum Interleukin-10 Level in Neonatal Hypoxic-ischemic Encephalopathy
下载PDF
导出
摘要 目的 研究新生儿缺氧缺血血性脑病 (HIE)患儿血白细胞介素 10 (IL 10 )水平变化 ,探讨IL 10水平与HIE之间的关系。方法 采用ELISA法测定新生儿血清IL 10水平 ,HIE组 2 0例和对照组 2 0例。标本取自本院 ,分 3组 ,HIE治疗前组、治疗后组和对照组。结果 HIE治疗前组IL 10水平中位数为 3 16pg/ml;明显高于对照组的 15 3pg ml和治疗后组的 12 3 5 9g ml;对照和治疗后组间差异无显著性。结论 新生儿HIE血清IL 10水平变化与HIE有关 ,IL 10在新生儿缺氧缺血性脑病的发病机理中起重要作用。 Objective To study the change of serum interleukin-10 (IL-10) level in neonatal hypoxic-ischemic encephalopathy (HIE), and explore the relationship between IL-10 and HIE. Methods Serum IL-10 was measured in 20 neonates with HIE before and after treatment as case group and in 20 neonates without HIE as control group respectively by enzyme-linked immunosorbent assay. Results Serum IL-10 level in the case group before treatment was highest, and there was no significant difference between the case group after treatment and control group. Conclusions The change of serum IL-10 level in neonatal HIE is related with the progress of HIE. IL-10 may play an important role in the pathogenesis of neonatal HIE.
出处 《浙江预防医学》 2003年第10期10-11,共2页 Zhejiang Journal of Preventive Medicine
关键词 新生儿缺氧缺血性脑病 血清 IL-10 临床意义 ELISA法 发病机理 Cerebral anoxia Cerebral ischemia Noenate Interleukin-10
  • 相关文献

参考文献4

二级参考文献17

  • 1Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin - 10and the interleukin-10 receptor[J]. Annu Rev Immunol, 2001, 19:683-765.
  • 2Gerosa F, Nisii C, Righetti S, et al. CD4 (+) T cell clones producingboth interferon -gamma and interleukin - 10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients[J]. Clin Immunol,1999,92(3):224- 234.
  • 3Roilides E, Sein T, Schaufele R, et al. Increased serum concentrationsof interleukin-10 in patients with hepatosplenic candidiasis[J]. JInfect Dis, 1998,178(2):589-592.
  • 4Mahanty S, Ravichandran M, Raman U, et al. Regulation ofparasite antigen-driven immune responses by interleukin-10 andIL-12 in lymphatic filariasis[J]. Infect lmmun, 1997,65(5):1742-1747.
  • 5Segal BM, Dwyer BK, Shevach EM, et al. An interleukin (IL)- 10/IL- 12 immunoregulatory circuit controls susceptibility to autoimmunedisease[J]. J Exp Med, 1998,187(4):537-546.
  • 6Zheng XX, Steele AW, Hancock WW, et al. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotessuppressor phenomena in NOD mice[J]. J Immunol, 1997,158(9):4507-4513.
  • 7Moritani M, Yoshimoto K, Ii S, et al. Prevention of adoptivelytransferred diabetes in nonobese diabetic mice with IL- 10-transducedislet-specific Thl lymphocytes. A gene therapy model forautoimmune diabetes[J]. J Clin Invest, 1996,98(8):1851-1859.
  • 8O'Garra A, Steinman L, Gijbels K, et al. CD4+ T-cell subsets inautoimmunity[J]. Curr Opin Immunol, 1997,9(6):872-883.
  • 9Whalen JD, Lechman EL, Carlos CA, et al. Adenoviral transfer ofthe viral IL-10 gene periarticularly to mouse paws suppressesdevelopment of collagen-induced arthritis in both injected anduninjected paws[J]. J Immunol, 1999,162(6):3625-3632.
  • 10Emilie D, Mariette X. Interleukin 10: anw e therapeutic target insystemic lupus erythematosus?[J]. Joint Bone Spine, 2001,68(1): 4-5.

共引文献2815

同被引文献23

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部